AIDSVAX B/B Trial Statistics
- Volunteers completing three doses: 5,009
- Placebo recipients: 1,679
- AIDSVAX B/B recipients: 3,330
- White volunteers: 4,185
- Hispanic volunteers: 326
- Non-white volunteers: 498
- Black volunteers: 314
- Annual study infection rate: 2.7%
Approximate efficacy (after at least 3 primary doses):
— All volunteers: 3.8% (p-value = 0.76)
— Non-white volunteers: 67% (p-value < 0.01)
— Black volunteers: 78% (p-value < 0.02)
AIDSVAX B/B Trial StatisticsArticle Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content